Hyperhomocysteinaemia, low folate concentrations and MTHFR C677T mutation in abdominal aortic aneurysm;Hyperhomocysteinämie, niedrige Folatkonzentrationen und MTHFR C677T Mutation beim Bauchaortenaneurysma

Vasa - European Journal of Vascular Medicine

Volumn 43, Issue 3, 2014, Pages 181-188

  Cao, Hui ^a   Hu, Xinhua ^a   Zhang, Qiang ^a   Li, Jun ^a   Liu, Bing ^b   Wang, Junpeng ^a   Shao, Yang ^a   Zhang, Zhishen ^a   Liu, Chengwei ^a   Hu, Haidi ^a   Zhang, Jian ^a   Xin, Shijie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

Abdominal aortic aneurysm; Folate; Homocysteine; Methylene tetrahydrofolate reductase

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA BIFURCATION; ARTICLE; BODY MASS; CHINA; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; RISK FACTOR;

ABDOMINAL AORTIC ANEURYSM; FOLATE; HOMOCYSTEINE; METHYLENE TETRAHYDROFOLATE REDUCTASE; VITAMIN B12;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; AORTOGRAPHY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PHENOTYPE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN B 12;

EID: 84900457311     PISSN: 03011526     EISSN: 16642872     Source Type: Journal    
DOI: 10.1024/0301-1526/a000347     Document Type: Article

References (31)

1. Moxon JV, Parr A, Emeto TI, Walker P, Norman PE, Golledge J. Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr Probl Cardiol 2010; 35; 512-548.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, Mc-Guire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Executive summary: heart disease and stroke statistics- 2013 update: a report from the American Heart Association. Circulation 2013; 127; 143-152.
3. Golledge J, Norman PE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 2011; 217; 57-63.
4. Kurvers H, Veith FJ, Lipsitz EC, Ohki T, Gargiulo NJ, Cayne NS, Suggs WD, Timaran CH, Kwon GY, Rhee SJ, Santiago C. Discontinuous, staccato growth of abdominal aortic aneurysms. J Am Coll Surg 2004; 199; 709-715.
5. Li ZY, Sadat U, J UK-I, Tang TY, Bowden DJ, Hayes PD, Gillard JH. Association between aneurysm shoulder stress and abdominal aortic aneurysm expansion: a longitudinal follow-up study. Circulation 2010; 122; 1815-1822.
6. Poon JT, Cheng SW, Wong JS, Ting AC. Prevalence of abdominal aortic aneurysm in Chinese patients with severe coronary artery disease. ANZ J Surg 2010; 80; 630-633.
7. Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 2011; 473; 308-316.
8. Marti-Carvajal AJ, Sola I, Lathyris D, Karakitsiou DE, Simancas-Racines D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2013; 1: CD006612.
9. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. BMJ 2002; 325; 1202.
10. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274; 1049-1057.
11. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19; 217-246.
12. He JA, Hu XH, Fan YY, Yang J, Zhang ZS, Liu CW, Yang DH, Zhang J, Xin SJ, Zhang Q, Duan ZQ. Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis. Eur J Vasc Endovasc Surg 2010; 39; 508-513.
13. Wald DS, Morris JK, Wald NJ. Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PloS one 2011; 6: e16473.
14. Selhub J. Th e many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 2006; 136; 1726S-1730S.
15. Wong YY, Golledge J, Flicker L, McCaul KA, Hankey GJ, van Bockxmeer FM, Yeap BB, Norman PE. Plasma total homocysteine is associated with abdominal aortic aneurysm and aortic diameter in older men. J Vasc Surg 2013; 58; 364-370.
16. Giusti B, Saracini C, Bolli P, Magi A, Sestini I, Sticchi E, Pratesi G, Pulli R, Pratesi C, Abbate R. Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm. J Med Genet 2008; 45; 721-730.
17. Sofi F, Marcucci R, Giusti B, Pratesi G, Lari B, Sestini I, Lo Sapio P, Pulli R, Pratesi C, Abbate R, Gensini GF. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm. Th romb Haemost 2005; 94; 1094-1098.
18. Warsi AA, Davies B, Morris-Stiff G, Hullin D, Lewis MH. Abdominal aortic aneurysm and its correlation to plasma homocysteine, and vitamins. Eur J Vasc Endovasc Surg 2004; 27; 75-79.
19. Spark JI, Laws P, Fitridge R. Th e incidence of hyperhomocysteinaemia in vascular patients. Eur J Vasc Endovasc Surg 2003; 26; 558-561.
20. Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R, Pepe G. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 2000; 32; 531-536.
21. Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx analyzer. Clin Chem 1999; 45; 569-571.
22. Maron BA, Loscalzo J. Should hyperhomocysteinemia be treated in patients with atherosclerotic disease? Curr Atheroscler Rep 2007; 9; 375-383.
23. Cheng X. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events. Cardiovasc Th er 2013; 31: e19-26.
24. Jones GT, Harris EL, Phillips LV, van Rij AM. Th e methylenetetrahydrofolate reductase C677T polymorphism does not associate with susceptibility to abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2005; 30; 137-142.
25. Peeters AC, van Landeghem BA, Graafsma SJ, Kranendonk SE, Hermus AR, Blom HJ, den Heijer M. Low vitamin B6, and not plasma homocysteine concentration, as risk factor for abdominal aortic aneurysm: a retrospective casecontrol study. J Vasc Surg 2007; 45; 701-705.
26. Strauss E, Waliszewski K, Gabriel M, Zapalski S, Pawlak AL. Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele. J Appl Genet 2003; 44; 85-93.
27. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999; 131; 331-339.
28. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function aft er oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000; 102; 2479-2483.
29. Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol 2013; 61; 289-294.
30. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002; 132; 2361S-2366S.
31. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270; 2693-2698.